Preliminary evidence that syrosingopine produces a selective depletion of central stores of sympathomimetic amines.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism; D013566:Sympathomimetics / Q000378:metabolism*
D013566:Sympathomimetics; D012701:Serotonin; D012110:Reserpine; D004298:Dopamine; D010433:Pentylenetetrazole; D009638:Norepinephrine